menu
    • menu

    Company profile for TME Pharma

    NEW Drugs in Dev: 4
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    TME Pharma is a clinical-stage company focusing on developing novel therapies for treatment of the most aggressive cancers. We specialize in approaches targeting the tumor microenvironment (TME) in which cancer cells exist. Our unique technology breaks tumor protection barriers against the immune system and blocks tumor repair by neutralizing chemokines in the TME. TME Pharma’s approach works in combination with other forms ...
    TME Pharma is a clinical-stage company focusing on developing novel therapies for treatment of the most aggressive cancers. We specialize in approaches targeting the tumor microenvironment (TME) in which cancer cells exist. Our unique technology breaks tumor protection barriers against the immune system and blocks tumor repair by neutralizing chemokines in the TME. TME Pharma’s approach works in combination with other forms of treatment to weaken tumor defenses and enable greater therapeutic impact. Our clinical programs in glioblastoma and pancreatic cancer have delivered very promising results and further development is planned.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TME PharmaGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Max-Dohrn-Strasse 8-10 10589 Berlin
    Telephone
    Telephone
    +49 30 726247 0
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tmepharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tme-pharma/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/tme_pharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TME PHARMA Calls 2026 Shareholders Meeting
    TME PHARMA Calls 2026 Shareholders Meeting

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299580/0/en/tme-pharma-announces-convocation-of-the-2026-annual-general-meeting-of-shareholders.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    TME Pharma Releases Annual Financial Results And Report
    TME Pharma Releases Annual Financial Results And Report

    30 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7256017

    FIRSTWORD PHARMA
    30 Apr 2026
    Share Share
    TME Pharma Publishes Phase 1/2 NOX-A12 Trial Results
    TME Pharma Publishes Phase 1/2 NOX-A12 Trial Results

    16 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/16/3275041/0/en/TME-Pharma-Announces-Publication-of-NOX-A12-Triple-Therapy-Phase-1-2-Expansion-Arm-A-Findings-from-GLORIA-trial-in-Nature-Communications.html

    GLOBENEWSWIRE
    16 Apr 2026
    Share Share
    TME Pharma Extends Financial Runway To Over 12 Months
    TME Pharma Extends Financial Runway To Over 12 Months

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251532/0/en/TME-Pharma-extends-financial-runway-to-over-12-months.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    TME Pharma Provides Update On Its Activities
    TME Pharma Provides Update On Its Activities

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212445/0/en/TME-Pharma-provides-update-on-its-activities.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    TME Pharma Receives In-Principle Bond Extension Agreements
    TME Pharma Receives In-Principle Bond Extension Agreements

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3188821/0/en/TME-Pharma-announces-receipt-of-agreements-in-principle-to-extend-certain-bond-agreements.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search